RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. et al
| RIGEL PHARMACEUTICALS, INC. |
| ANNORA PHARMA PRIVATE LTD., HETERO LABS LTD. and HETERO USA, INC. |
| 3:2022cv04732 |
| July 25, 2022 |
| US District Court for the District of New Jersey |
| Evelyn Padin |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 25, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Corporate Disclosure Statement by RIGEL PHARMACEUTICALS, INC.. (LIZZA, CHARLES) |
| Filing 1 COMPLAINT against ANNORA PHARMA PRIVATE LTD., HETERO LABS LTD., HETERO USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13584976), filed by RIGEL PHARMACEUTICALS, INC.. (Attachments: #1 Civil Cover Sheet)(LIZZA, CHARLES) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
